| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 856 |
| 1 | MYCOPHENOLATE MOFETIL | 727 |
| 2 | TACROLIMUS CAPSULES | 508 |
| 3 | CYCLOSPORINE | 474 |
| 4 | SIROLIMUS | 464 |
| 5 | ETANERCEPT | 448 |
| 6 | INFLIXIMAB | 396 |
| 7 | PREDNISONE | 197 |
| 8 | SULFASALAZINE | 176 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 134 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SIROLIMUS | 464 | 0.0360 |
| 1 | BENZNIDAZOLE | 1 | 0.0172 |
| 2 | FOSCARNET SODIUM | 39 | 0.0170 |
| 3 | BASILIXIMAB | 75 | 0.0110 |
| 4 | MYCOPHENOLATE MOFETIL | 727 | 0.0108 |
| 5 | TACROLIMUS | 856 | 0.0102 |
| 6 | VALGANCICLOVIR HYDROCHLORIDE | 93 | 0.0096 |
| 7 | TACROLIMUS CAPSULES | 508 | 0.0091 |
| 8 | THIOTEPA | 39 | 0.0083 |
| 9 | CYCLOSPORINE | 474 | 0.0076 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 475 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 474 |
| 2 | mTOR Inhibitor Immunosuppressant [EPC] | 472 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 450 |
| 4 | Corticosteroid [EPC] | 354 |
| 5 | Aminosalicylate [EPC] | 176 |
| 6 | Alkylating Drug [EPC] | 82 |
| 7 | Interleukin-2 Receptor Blocking Antibody [EPC] | 75 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 63 |
| 9 | Purine Antimetabolite [EPC] | 48 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-2 Receptor Blocking Antibody [EPC] | 75 | 0.0110 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 63 | 0.0098 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 474 | 0.0072 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 30 | 0.0054 |
| 4 | Immunoglobulin G [EPC] | 28 | 0.0050 |
| 5 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0035 |
| 6 | Aminosalicylate [EPC] | 176 | 0.0024 |
| 7 | CCR5 Co-receptor Antagonist [EPC] | 4 | 0.0023 |
| 8 | Osmotic Diuretic [EPC] | 7 | 0.0022 |
| 9 | Selective T Cell Costimulation Blocker [EPC] | 5 | 0.0022 |